Trial intelligence / Profile preview

Surufatinib vs capecitabine in unresectable or metastatic biliary tract cancer (2nd line)

CTR20181945Phase 3Terminated

Sponsor

HUTCHMED

Start

Oct 2018

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules

Countries

1